Hot Medical Stocks For 2019


Senators Explore Bipartisan `Plan B’ to Troubled GOP Health Bill

5 Top States for Annuity Payment Growth

How the Survival of the Affordable Care Act Could Affect You

The new version of the Senate’s Affordable Care Act change bill could strip many federal rules from the off-exchange individual major medical market, and nudge the public health insurance system to focus on serving people with health problems.

The Senate Budget Committee posted a copy of the Better Care Reconciliation Act bill update today on its website. A copy of the bill is available here. 

Sen. Lisa Murkowski, R-Alaska (Photo: Murkowski)

Seema Verma asked for ideas about how to make things better. You replied.

You are signed up!

Your resource for news, research and analysis to help you deliver more effective outcomes to your clients. width:300px!important;max-height:36px; ThinkAdvisor TechCenter


ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources How to thrive in a post-DOL rule world

Tools to help you survive in the post-DOL rule world.

Hot Medical Stocks For 2019: iAnthus Capital Holdings, Inc. (ITHUF)


Advisors’ Opinion:

  • [By Sean Williams]

    There’s also the more than $600 million deal between iAnthus Capital Holdings (NASDAQOTH:ITHUF) and MPX Bioceutical, which recently closed. Following closure, iAnthus Capital now has a presence in 11 U.S. states, with 19 open dispensaries. However, the combined retail dispensary license count is 63, meaning iAnthus has a path to significant storefront growth, and a planned tripling in its cultivation capacity, too.

  • [By Javier Hasse]

    Licensed cannabis production facilities owner and operator iAnthus Capital Holdings Inc (OTC: ITHUF) announced a $50 million investment from Gotham Green Partners. Management believes this is the largest investment to date by a single investor in a publicly traded U.S. cannabis operating company. iAnthus plans to allocate the proceeds of this financing to repay a $20 million one-year note and accrued interest to VCP Bridge LLC; continue to build out cultivation facilities and dispensaries in the New York and Florida markets; and, potentially, to expand activities. The remaining expenditures for completing iAnthus’ Massachusetts and Vermont operations will be funded with current cash on hand, management assured.

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million


    Biotech

  • [By Keith Speights]

    What about Florida? If you want to stick with marijuana growers, one possibility is iAnthus Capital Holdings (NASDAQOTH:ITHUF). The company holds one of only 13 cannabis licenses in Florida and also has operations in three other states. Its stock ranked as the No. 2 best-performing marijuana stock in the first half of 2018.

Hot Medical Stocks For 2019: CVB Financial Corporation(CVBF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on CVB Financial (CVBF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    CVB Financial (NASDAQ:CVBF) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Thursday.

  • [By Shane Hupp]

    Glen Harbor Capital Management LLC reduced its holdings in CVB Financial Co. (NASDAQ:CVBF) by 45.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,054 shares of the financial services provider’s stock after selling 17,754 shares during the period. Glen Harbor Capital Management LLC’s holdings in CVB Financial were worth $477,000 as of its most recent filing with the Securities and Exchange Commission.

Hot Medical Stocks For 2019: Alexandria Real Estate Equities, Inc.(ARE)


Advisors’ Opinion:

  • [By Logan Wallace]

    Alexandria Real Estate Equities (NYSE:ARE) issued an update on its FY19 earnings guidance on Monday morning. The company provided earnings per share guidance of $6.85-$7.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.94. Alexandria Real Estate Equities also updated its FY 2019 guidance to $6.85-7.05 EPS.

  • [By Stephan Byrd]

    Aecon Group Inc. (TSE:ARE) – Stock analysts at Desjardins cut their FY2018 earnings estimates for Aecon Group in a research note issued to investors on Thursday, May 24th. Desjardins analyst B. Poirier now forecasts that the company will post earnings of $0.96 per share for the year, down from their prior forecast of $1.14. Desjardins currently has a “Buy” rating on the stock.

  • [By Joseph Griffin]

    Alexandria Real Estate Equities Inc (NYSE:ARE) insider Dean A. Shigenaga sold 9,000 shares of the business’s stock in a transaction dated Monday, August 20th. The shares were sold at an average price of $129.59, for a total value of $1,166,310.00. Following the completion of the transaction, the insider now directly owns 148,645 shares of the company’s stock, valued at approximately $19,262,905.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Todd Campbell]

    It’s not just tech companies that can trace their roots back to a garage. According to co-founder Joel Marcus, Alexandria Real Estate Equities (NYSE:ARE) — a real estate investment trust specializing in life sciences laboratory and office space — got its start in a garage, too. Since its founding in 1994, Alexandria Real Estate has grown into an $18 billion commercial real estate Goliath with $1.1 billion in annual revenue. Can this company’s success continue? I recently spoke with Marcus to learn more about the company and its opportunities.

  • [By Max Byerly]

    Bank of Nova Scotia trimmed its stake in shares of Alexandria Real Estate Equities Inc (NYSE:ARE) by 12.2% during the second quarter, HoldingsChannel reports. The institutional investor owned 11,358 shares of the real estate investment trust’s stock after selling 1,574 shares during the period. Bank of Nova Scotia’s holdings in Alexandria Real Estate Equities were worth $1,434,000 at the end of the most recent reporting period.

Leave a Reply

Your email address will not be published.